Resources - Search Results | Barrington James

Back to resources

Search Results for "cmo-cdmo"

Displaying 1 - 8 of 11

Biotechnology, Medical Device
Q2 Boardroom Reckoning: What Q1 Made Clear
Amid breakthrough discovery, digital transformation, and shifting regulation, life sciences ...

By Barrington James March 31st, 2026
Pharmaceutical, CRO, Contract Outsourcing
Navigating 503B Outsourcing Trends and 2026 Outlook
The U.S. compounding landscape changed substantially when the United States Pharmacopeia (US...

By Barrington James January 28th, 2026
2025 in Review: Strategic Maturity in Life Sciences
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...

By Barrington James December 16th, 2025
JP Morgan Healthcare Conference 2025: Key Biopharma Trends, Hiring Challenges & Market Recovery
The 43rd Annual JP Morgan Healthcare Conference was held in San Francisco last month. The mo...

By Barrington James February 6th, 2025
Contract Outsourcing
CDMO/CMO Sector Trends & Challenges
The CDMO/CMO market is experiencing significant growth, particularly in the Drug Substance A...

By Barrington James January 30th, 2025
Contract Outsourcing
Reduced Turnover and Accelerated Growth for a Small Molecule CDMO
The ChallengeA small molecule CDMO faced over a 70% turnover rate, struggled to meet product...

By Barrington James January 28th, 2025
CRO
Specialized Talent Acquisition for CRO Growth in Metabolic Patient Site Services
We supported 57 hires over five years, driving CRO expansion, market share growth, and reput...

By Barrington James November 22nd, 2024
Contract Outsourcing
Strategic Recruitment Partnership for Small Molecule CDMO Expansion
We reduced turnover from 70% to 11%, placing 13 hires and enabling global expansion for a CD...

By Barrington James November 20th, 2024